Balance Sheet
Cash Flow Statement
AmortizationAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Capital Expenditures (2024 - 2025)

Historic Capital Expenditures for Dr Reddys Laboratories (RDY) over the last 3 years, with Q3 2025 value amounting to -$59.9 million.

  • Dr Reddys Laboratories' Capital Expenditures rose 3346.43% to -$59.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$291.3 million, marking a year-over-year decrease of 5809.75%. This contributed to the annual value of $322.0 million for FY2025, which is 6345.18% up from last year.
  • According to the latest figures from Q3 2025, Dr Reddys Laboratories' Capital Expenditures is -$59.9 million, which was up 3346.43% from -$80.2 million recorded in Q2 2025.
  • In the past 5 years, Dr Reddys Laboratories' Capital Expenditures ranged from a high of -$59.9 million in Q3 2025 and a low of -$90.0 million during Q3 2024